Aptamers for Targeting SARS-CoV-2 Proteins

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays.

Illustration of an Aptamer interacting with a target protein. Image credit: AMS Bio

Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a target. This target can be an organic molecule, free or carried in cells or tissues, or inorganic components, such as metal ions. Aptamers have generated significant interest as promising tools, that compete with monoclonal antibodies, for detection and inhibition of specific markers of human diseases because they offer high specificity for their target, no to low immunogenicity and easy in vitro selection.

To better understand the genetic architecture of host proteins interacting with SARS-CoV-2 or mediating host response to COVID-19 - using an aptamer-based technique can help to identify new or repurpose existing drugs targeting those proteins.

As aptamers bind targets with high selectivity and specificity, they are an ideal tool to help develop new approaches to early-stage diagnostic assay and adequate therapy. With AMSBIO aptamers targeting SARS-CoV-2 S1 protein, S2 protein, RBD protein or nucleocapsid protein, they can be used in wide range of detection methods and for development of COVID-19 diagnostic assays.

For further information on the new range of aptamers targeting SARS-CoV-2 proteins please visit https://www.amsbio.com/aptamers-for-infectious-diseases/ or contact AMSBIO on+44-1235-828200 / +1-617-945-5033 / [email protected].


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2021, November 05). Aptamers for Targeting SARS-CoV-2 Proteins. AZoLifeSciences. Retrieved on July 21, 2024 from https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx.

  • MLA

    AMS Biotechnology. "Aptamers for Targeting SARS-CoV-2 Proteins". AZoLifeSciences. 21 July 2024. <https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx>.

  • Chicago

    AMS Biotechnology. "Aptamers for Targeting SARS-CoV-2 Proteins". AZoLifeSciences. https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx. (accessed July 21, 2024).

  • Harvard

    AMS Biotechnology. 2021. Aptamers for Targeting SARS-CoV-2 Proteins. AZoLifeSciences, viewed 21 July 2024, https://www.azolifesciences.com/news/20210915/Aptamers-for-Targeting-SARS-CoV-2-Proteins.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cryopreservation Excipient for Cell Therapies